CoChat

Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Peptides have potential to be developed into immune checkpoint inhibitors, but the target interfaces are difficult to inhibit. Here, we explored an approach to mimic the binding surface of PD-1 to design inhibitors. Mimicking native PD-1 resulted in a mimetic with no activity. However, mimicking an affinity-optimized PD-1 resulted in the peptide mimetic MOPD-1 that displayed nanomolar affinity to PD-L1 and could inhibit PD-1:PD-L1 interactions in both protein- and cell-based assays. Mutagenesis and structural characterization using NMR spectroscopy and X-ray crystallography revealed that binding residues from the high affinity PD-1 are crucial for the bioactivity of MOPD-1. Furthermore, MOPD-1 was extremely stable in human serum and inhibited tumor growth in vivo, suggesting it has potential for use in cancer immunotherapy. The successful design of an inhibitor of PD-1:PD-L1 using the mimicry approach described herein illustrates the value of placing greater emphasis on optimizing the target interface before inhibitor design and is an approach that could have broader utility for the design of peptide inhibitors for other complex protein–protein interactions.

Overview

Integrity signals

Registry

Crossref · 10.1021/jacs.1c08132

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

Metadata

Authors
Yin, H., Zhou, X., Huang, Y.-H., King, G. J., Collins, B. M., Gao, Y., Craik, D. J., & Wang, C. K.
Affiliations
  • The University of Queensland (AU)
  • Zhengzhou University (CN)
  • Sun Yat-sen University (CN)
Corresponding author
  • Craik, David J.
  • Wang, Conan K.
Venue
Journal of the American Chemical Society
Published
2021-10-18
Volume
143
Issue
44
Pages
18536-18547
ISSN
  • 0002-7863 (ISSN-L)
  • 1520-5126
OpenAlex
W3207145203
Cited by
57
References
49
Citations by year
2026: 8 · 2025: 14 · 2024: 16 · 2023: 10 · 2022: 9
FWCI
2.82
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Chemical Society (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Health and Medical Research Council (APP1084965, APP1136021)
  • Australian Research Council (FL150100146)
  • China Scholarship Council
  • National Natural Science Foundation of China (U20A20369)
Topics
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
PD-1/PD-L1 interaction, peptide inhibitors, immune checkpoint inhibitors, cancer immunotherapy, protein-protein interaction inhibition, serum stability, tumor growth inhibition, structure-based inhibitor design
MeSH terms
Immune Checkpoint Inhibitors, Amino Acid Sequence, Animals, Antineoplastic Agents, Female, Humans, Immunotherapy, Mice, Inbred BALB C, Neoplasms, Neoplasms, Experimental, Mice, B7-H1 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.